Millipore Posts 38-Percent Rise in Q3 Revenue as Profit Slips 35 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Millipore yesterday said third-quarter revenues increased 38 percent as R&D spending rose 31 percent and profits slid 35 percent.
 
Total receipts for the three months ended Sept. 30 increased to $330.1 million from $239.6 million year over year. Compared with the third quarter of 2005, sales in the company’s Bioprocess segment was up 34 percent to $195 million, while its Bioscience segment gained 44 percent with sales of $135 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.